2021 ACC专家共识决策路径:优化心力衰竭的治疗(更新版)

2021-01-11 美国心脏病学会 J Am Coll Cardiol.Jan 11, 2021.

2021年1月,美国心脏病学会(ACC)更新发布了优化心力衰竭的治疗的专家共识决策路径:回答射血分数降低心衰的10个关键问题。更新的建议包括:(1)在不进行血管紧张素转换酶抑制剂(ACEI)/血管紧张

中文标题:

2021 ACC专家共识决策路径:优化心力衰竭的治疗(更新版)

英文标题:

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction

发布机构:

美国心脏病学会

发布日期:

2021-01-11

简要介绍:

2021年1月,美国心脏病学会(ACC)更新发布了优化心力衰竭的治疗的专家共识决策路径:回答射血分数降低心衰的10个关键问题。更新的建议包括:(1)在不进行血管紧张素转换酶抑制剂(ACEI)/血管紧张素受体阻滞剂(ARB)预处理的情况下先使用沙库巴曲/缬沙坦;(2)SGLT2i用于伴或不伴糖尿病的HFrEF患者。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ACC专家共识决策路径:优化心力衰竭的治疗(更新版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=4bba21c0020392d4, title=2021 ACC专家共识决策路径:优化心力衰竭的治疗(更新版), enTitle=2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction, guiderFrom=J Am Coll Cardiol.Jan 11, 2021., authorId=0, author=, summary=2021年1月,美国心脏病学会(ACC)更新发布了优化心力衰竭的治疗的专家共识决策路径:回答射血分数降低心衰的10个关键问题。更新的建议包括:(1)在不进行血管紧张素转换酶抑制剂(ACEI)/血管紧张, cover=https://img.medsci.cn/2021121/1611241536587_2020535.jpg, journalId=0, articlesId=null, associationId=849, associationName=美国心脏病学会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Jan 11 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年1月,美国心脏病学会(ACC)更新发布了优化心力衰竭的治疗的专家共识决策路径:回答射血分数降低心衰的10个关键问题。更新的建议包括:(1)在不进行血管紧张素转换酶抑制剂(ACEI)/血管紧张素受体阻滞剂(ARB)预处理的情况下先使用沙库巴曲/缬沙坦;(2)SGLT2i用于伴或不伴糖尿病的HFrEF患者。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=335, tagName=心力衰竭)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=335, guiderKeyword=心力衰竭, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7404, appHits=332, showAppHits=0, pcHits=2102, showPcHits=7072, likes=6, shares=34, comments=19, approvalStatus=1, publishedTime=Thu Jan 21 23:41:11 CST 2021, publishedTimeString=2021-01-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Jan 21 23:05:41 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Tue Jan 02 15:05:57 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ACC专家共识决策路径:优化心力衰竭的治疗(更新版).pdf)])
2021 ACC专家共识决策路径:优化心力衰竭的治疗(更新版).pdf
下载请点击:
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1077184, encodeId=e0c810e71848d, content=我操了全是英文,要我老命, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80785480209, createdName=ms9000001118493946, createdTime=Sun Dec 05 23:06:14 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969759, encodeId=ca81969e598b, content=及时更新!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=彧日东升, createdTime=Mon May 31 04:51:34 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968640, encodeId=0e6396864081, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e2a5507988, createdName=打怪兽的女超人, createdTime=Wed May 26 14:42:36 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967356, encodeId=addc96e3565e, content=非常好的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/1ae5a22e12934d1490a0aa37c3b438bc/a17477a73fc24681999add8c78cc8d7b.jpg, createdBy=6c095505442, createdName=Dr Peng, createdTime=Fri May 21 00:01:33 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967171, encodeId=e8a996e1711c, content=刚刚, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80785480209, createdName=ms9000001118493946, createdTime=Thu May 20 09:51:35 CST 2021, time=2021-05-20, status=1, ipAttribution=)]
    2021-12-05 ms9000001118493946

    我操了全是英文,要我老命

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1077184, encodeId=e0c810e71848d, content=我操了全是英文,要我老命, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80785480209, createdName=ms9000001118493946, createdTime=Sun Dec 05 23:06:14 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969759, encodeId=ca81969e598b, content=及时更新!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=彧日东升, createdTime=Mon May 31 04:51:34 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968640, encodeId=0e6396864081, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e2a5507988, createdName=打怪兽的女超人, createdTime=Wed May 26 14:42:36 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967356, encodeId=addc96e3565e, content=非常好的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/1ae5a22e12934d1490a0aa37c3b438bc/a17477a73fc24681999add8c78cc8d7b.jpg, createdBy=6c095505442, createdName=Dr Peng, createdTime=Fri May 21 00:01:33 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967171, encodeId=e8a996e1711c, content=刚刚, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80785480209, createdName=ms9000001118493946, createdTime=Thu May 20 09:51:35 CST 2021, time=2021-05-20, status=1, ipAttribution=)]
    2021-05-31 彧日东升

    及时更新!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1077184, encodeId=e0c810e71848d, content=我操了全是英文,要我老命, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80785480209, createdName=ms9000001118493946, createdTime=Sun Dec 05 23:06:14 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969759, encodeId=ca81969e598b, content=及时更新!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=彧日东升, createdTime=Mon May 31 04:51:34 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968640, encodeId=0e6396864081, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e2a5507988, createdName=打怪兽的女超人, createdTime=Wed May 26 14:42:36 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967356, encodeId=addc96e3565e, content=非常好的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/1ae5a22e12934d1490a0aa37c3b438bc/a17477a73fc24681999add8c78cc8d7b.jpg, createdBy=6c095505442, createdName=Dr Peng, createdTime=Fri May 21 00:01:33 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967171, encodeId=e8a996e1711c, content=刚刚, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80785480209, createdName=ms9000001118493946, createdTime=Thu May 20 09:51:35 CST 2021, time=2021-05-20, status=1, ipAttribution=)]
    2021-05-26 打怪兽的女超人

    谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1077184, encodeId=e0c810e71848d, content=我操了全是英文,要我老命, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80785480209, createdName=ms9000001118493946, createdTime=Sun Dec 05 23:06:14 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969759, encodeId=ca81969e598b, content=及时更新!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=彧日东升, createdTime=Mon May 31 04:51:34 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968640, encodeId=0e6396864081, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e2a5507988, createdName=打怪兽的女超人, createdTime=Wed May 26 14:42:36 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967356, encodeId=addc96e3565e, content=非常好的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/1ae5a22e12934d1490a0aa37c3b438bc/a17477a73fc24681999add8c78cc8d7b.jpg, createdBy=6c095505442, createdName=Dr Peng, createdTime=Fri May 21 00:01:33 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967171, encodeId=e8a996e1711c, content=刚刚, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80785480209, createdName=ms9000001118493946, createdTime=Thu May 20 09:51:35 CST 2021, time=2021-05-20, status=1, ipAttribution=)]
    2021-05-21 Dr Peng

    非常好的分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1077184, encodeId=e0c810e71848d, content=我操了全是英文,要我老命, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80785480209, createdName=ms9000001118493946, createdTime=Sun Dec 05 23:06:14 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969759, encodeId=ca81969e598b, content=及时更新!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=彧日东升, createdTime=Mon May 31 04:51:34 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968640, encodeId=0e6396864081, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e2a5507988, createdName=打怪兽的女超人, createdTime=Wed May 26 14:42:36 CST 2021, time=2021-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967356, encodeId=addc96e3565e, content=非常好的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/1ae5a22e12934d1490a0aa37c3b438bc/a17477a73fc24681999add8c78cc8d7b.jpg, createdBy=6c095505442, createdName=Dr Peng, createdTime=Fri May 21 00:01:33 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967171, encodeId=e8a996e1711c, content=刚刚, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80785480209, createdName=ms9000001118493946, createdTime=Thu May 20 09:51:35 CST 2021, time=2021-05-20, status=1, ipAttribution=)]
    2021-05-20 ms9000001118493946

    刚刚

    0

拓展阅读

2010 中华医学会 急性心力衰竭诊断和治疗指南

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2010-01-01

心脏再同步治疗慢性心力衰竭的建议(2009年修订版)

中华医学会心电生理和起搏分会 · 2010-02-25

2010HFSA 心力衰竭治疗指南

美国心衰学会(HFSA,HEART FAILURE SOCIETY OF AMERICA) · 2010-07-01

2012AHA 科学声明:心力衰竭诊疗进展科学决策

美国心脏协会(AHA,American Heart Association) · 2012-03-05